{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:01:43Z","timestamp":1780290103706,"version":"3.54.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The uric acid-to-high-density lipoprotein cholesterol ratio (UHR) is a composite biomarker that reflects both oxidative stress and antioxidant imbalance. Previous studies have linked UHR to poor prognosis in heart failure (HF), but the evidence relies largely on traditional regression models; it lacks independent validation and has not been integrated into modern, individualized risk-prediction tools. This study aimed to independently validate the association between UHR and a 180-day composite outcome (all-cause death or HF rehospitalization) in a relatively large HF cohort, and to construct an interpretable machine learning model that incorporates UHR and routine clinical indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a single-center retrospective cohort study that consecutively enrolled 2,737 patients with heart failure hospitalized at Beijing Anzhen Hospital, Capital Medical University, from January 1, 2024, to June 30, 2025. All patients were followed up until December 31, 2025, to ensure complete 180-day follow-up data for each patient. The primary outcome was a composite endpoint of all-cause death or heart failure rehospitalization within 180\u202fdays. Multivariate Cox regression and restricted cubic splines (RCS) were used to analyze the association and dose\u2013response relationship between UHR and the composite outcome. Least Absolute Shrinkage and Selection Operator (LASSO) regression combined with multivariate Logistic regression was employed to screen predictive variables. Seven machine learning models were developed in the training set (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f1,917) and validated in an internal validation set (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f820). The optimal model was interpreted using the SHapley Additive exPlanations (SHAP) framework and deployed as an online calculator.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During follow-up, 926 patients (33.8%) experienced the composite outcome. UHR was confirmed as an independent risk factor for the composite outcome. RCS analysis revealed a nonlinear association. The eXtreme Gradient Boosting (XGBoost) model, constructed based on six variables: body mass index (BMI), history of hyperlipidemia, homocysteine (Hcy), glycated albumin (GA), small dense low-density lipoprotein cholesterol (sdLDL-C) and UHR, demonstrated the best performance. In the internal validation set, it achieved an AUC of 0.866 (95%CI, 0.839\u20130.890), with good calibration and high clinical net benefit in decision curve analysis. SHAP analysis identified sdLDL-C and UHR as the two most important predictive features and revealed nonlinear effects of the variables. The model was deployed as an online calculator (\n                      <jats:uri>https:\/\/machine11.shinyapps.io\/xgboostforUHR\/<\/jats:uri>\n                      ), which currently serves as a research demonstration platform and requires external validation before any clinical application.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>UHR is an independent risk factor for the 180-day composite outcome in HF patients. The XGBoost model based on UHR and five other routine clinical indicators shows good discrimination, calibration, and clinical net benefit. The online calculator provides an exploratory tool for short-term risk stratification but requires further external validation before clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1846081","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:19:06Z","timestamp":1780287546000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting short-term composite outcome risk in heart failure patients using a machine learning model incorporating UHR: a retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Yihe","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Medical Center of Chinese PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Third Medical Center of Chinese PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhu","family":"Nan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3390\/healthcare12131360","article-title":"Cost-utility analysis of 3-month telemedical intervention for heart failure patients: a preliminary study from Poland","volume":"12","author":"Wa\u0144czura","year":"2024","journal-title":"Health Care (Don Mills)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1002\/ehf2.14364","article-title":"Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan","volume":"10","author":"Naito","year":"2023","journal-title":"ESC Heart Fail"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1002\/ehf2.13646","article-title":"\u2018Time is prognosis\u2019 in heart failure: time-to-treatment initiation as a modifiable risk factor","volume":"8","author":"Abdin","year":"2021","journal-title":"ESC Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.jacc.2025.08.051","article-title":"Effect of vericiguat on total heart failure events in compensated outpatients with HFrEF: insights from VICTOR","volume":"86","author":"Zannad","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.3390\/ijms25052667","article-title":"Mitochondrial dysfunction in heart failure: from pathophysiological mechanisms to therapeutic opportunities","volume":"25","author":"Gallo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jare.2024.02.006","article-title":"Single-cell transcriptomic profiling of heart reveals ANGPTL4 linking fibroblasts and angiogenesis in heart failure with preserved ejection fraction","volume":"68","author":"Li","year":"2025","journal-title":"J Adv Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2024.08.026","article-title":"Triglyceride glucose (TyG) index: a promising biomarker for diagnosis and treatment of different diseases","volume":"131","author":"Sun","year":"2025","journal-title":"Eur J Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12933-025-02687-8","article-title":"Association of triglyceride-glucose index trajectories with the risk of worsening heart failure in elderly patients with chronic heart failure and type 2 diabetes: a competing risk analysis","volume":"24","author":"Lai","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-025-02807-z","article-title":"The combined association of the neutrophil percentage-to-albumin ratio (NPAR) and the uric acid-to-high-density lipoprotein cholesterol ratio (UHR) with adverse cardiac events in patients with chronic heart failure: a retrospective cohort study","volume":"25","author":"Fu","year":"2025","journal-title":"Lipids Health Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1164096","DOI":"10.3389\/fmed.2023.1164096","article-title":"Association of serum uric acid-to-high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease in American adults: a population-based analysis","volume":"10","author":"Xie","year":"2023","journal-title":"Front Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1417485","DOI":"10.3389\/fendo.2024.1417485","article-title":"The serum uric acid-to-high-density lipoprotein cholesterol ratio is a predictor for all-cause and cardiovascular disease mortality: a cross-sectional study","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/biom15070941","article-title":"Uric acid, the end-product of purine metabolism, mitigates tau-related abnormalities: comparison with DOT, a non-antibiotic oxytetracycline derivative","volume":"15","author":"Andretto de Mattos","year":"2025","journal-title":"Biomolecules"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11883-022-01012-y","article-title":"The role of high-density lipoprotein cholesterol in 2022","volume":"24","author":"Sirtori","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e12688","DOI":"10.1111\/cob.12688","article-title":"Cholesterol transfer to high-density lipoprotein in obesity and the effects of weight loss after bariatric surgery","volume":"14","author":"de Oliveira","year":"2024","journal-title":"Clin Obes"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1269580","DOI":"10.3389\/fendo.2023.1269580","article-title":"Association between cumulative uric acid to high-density lipoprotein cholesterol ratio and the incidence and progression of chronic kidney disease","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1723098","DOI":"10.3389\/fnut.2026.1723098","article-title":"A comprehensive study on the uric acid to high-density cholesterol ratio influencing cardiometabolic-based chronic disease in China","volume":"13","author":"Kahaer","year":"2026","journal-title":"Front Nutr"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e046606","DOI":"10.1161\/JAHA.125.046606","article-title":"Development and validation of a prognostic nomogram for post-transcatheter aortic valve replacement heart failure hospitalization in patients with concurrent symptomatic aortic stenosis and heart failure with preserved ejection fraction: a multicenter study","volume":"15","author":"Wang","year":"2026","journal-title":"J Am Heart Assoc"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e78402","DOI":"10.2196\/78402","article-title":"Multimodal data-driven explainable prognostic model for major adverse cardiovascular events prediction in patients with unstable angina and heart failure with preserved ejection fraction: multicenter, cross-regional cohort study","volume":"27","author":"Wang","year":"2025","journal-title":"J Med Internet Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e70587","DOI":"10.2196\/70587","article-title":"Multimodal visualization and explainable machine learning-driven markers enable early identification and prognosis prediction for symptomatic aortic stenosis and heart failure with preserved ejection fraction after transcatheter aortic valve replacement: multicenter cohort study","volume":"27","author":"Wang","year":"2025","journal-title":"J Med Internet Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.5551\/jat.65654","article-title":"The incremental prognostic value of incorporating the triglyceride-glucose index into the traditional cardiovascular risk factors for the long-term prognosis in ischemic cardiomyopathy patients with HFpEF following coronary artery bypass grafting: a multicenter cohort study","volume":"32","author":"Ruan","year":"2025","journal-title":"J Atheroscler Thromb"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/jcm15031056","article-title":"Patterns in prescribing and predictors of SGLT2 inhibitor administration in patients with heart failure and acute myocardial infarction: a real-world retrospective cohort study","volume":"15","author":"Suciu","year":"2026","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1113\/JP286410","article-title":"Distinguishing pathophysiological features of heart failure with reduced and preserved ejection fraction: a comparative analysis of two mouse models","author":"M\u00e9ndez-Fern\u00e1ndez","year":"2024","journal-title":"J Physiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10741-022-10274-2","article-title":"Sex differences and related estrogenic effects in heart failure with preserved ejection fraction","volume":"28","author":"Shuaishuai","year":"2023","journal-title":"Heart Fail Rev"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4250\/jcvi.2018.26.e22","article-title":"Pseudonormal or restrictive filling pattern of left ventricle predicts poor prognosis in patients with ischemic heart disease presenting as acute heart failure","volume":"26","author":"Lee","year":"2018","journal-title":"J Cardiovasc Imaging"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000520909","article-title":"Heart failure in patients with diabetes and chronic kidney disease: challenges and opportunities","volume":"12","author":"Vijay","year":"2022","journal-title":"Cardiorenal Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12944-025-02604-8","article-title":"Association of serum uric acid-to-high-density lipoprotein cholesterol ratio with obstructive sleep apnea: a cross-sectional study","volume":"24","author":"Tang","year":"2025","journal-title":"Lipids Health Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1186\/s40001-025-03084-3","article-title":"Association between uric acid to high-density lipoprotein cholesterol ratio (UHR) and female infertility: insights from a cross-sectional study","volume":"30","author":"Wang","year":"2025","journal-title":"Eur J Med Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2174\/0929867328666210714155422","article-title":"Environmental factors modifying HDL functionality","volume":"29","author":"Kosmas","year":"2022","journal-title":"Curr Med Chem"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1042\/CS20190873","article-title":"Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL","volume":"133","author":"Hui","year":"2019","journal-title":"Clin Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2017.06.007","article-title":"The usefulness of advanced lipid and oxidative stress testing for diagnosis and management of low HDL-cholesterol phenotype: a case report","volume":"50","author":"Kuburovic","year":"2017","journal-title":"Clin Biochem"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/ndt\/gfad201","article-title":"Serum uric acid levels and health outcomes in CKD: a prospective cohort study","volume":"39","author":"Wu","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e23582","DOI":"10.7759\/cureus.23582","article-title":"Elevated serum uric acid and cardiovascular disease: a review and potential therapeutic interventions","volume":"14","author":"Freilich","year":"2022","journal-title":"Cureus"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"8944","DOI":"10.1038\/s41598-025-93738-3","article-title":"Relationship between serum uric acid levels and metabolism associated fatty liver disease in postmenopausal women based on NHANES 2017-2020","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci Rep"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fendo.2020.00055","article-title":"The associations between gonadal hormones and serum uric acid levels in men and postmenopausal women with diabetes","volume":"11","author":"Wan","year":"2020","journal-title":"Front Endocrinol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12944-022-01653-7","article-title":"Measures of high-density lipoprotein function in men and women with severe aortic stenosis","volume":"21","author":"Hafiane","year":"2022","journal-title":"Lipids Health Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s12013-024-01512-5","article-title":"Hyperuricemia facilitates uric acid-mediated vascular endothelial cell damage by inhibiting mitophagy","volume":"83","author":"Wu","year":"2025","journal-title":"Cell Biochem Biophys"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1046410","DOI":"10.3389\/fimmu.2022.1046410","article-title":"Identification of immune microenvironment subtypes and signature genes for alzheimer\u2019s disease diagnosis and risk prediction based on explainable machine learning","volume":"13","author":"Lai","year":"2022","journal-title":"Front Immunol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e0319851","DOI":"10.1371\/journal.pone.0319851","article-title":"Machine learning for predicting metabolic-associated fatty liver disease including NHHR: a cross-sectional NHANES study","volume":"20","author":"Lin","year":"2025","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0895-4356(96)00002-9","article-title":"Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes","volume":"49","author":"Tu","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1057\/s41285-017-0055-0","article-title":"In BMI we trust: reframing the body mass index as a measure of health","volume":"16","author":"Gutin","year":"2018","journal-title":"Soc Theory Health"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.31348\/2018\/1\/1-4-2018","article-title":"Diagnosis of familial hypercholesterolaemia on first sight? The role of the ophthalmologist in identifying patients with familial hypercholesterolaemia","volume":"74","author":"Altschmiedov\u00e1","year":"2019","journal-title":"Ces Slov Oftalmol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/cir.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.biochi.2020.02.012","article-title":"Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arterial wall","volume":"173","author":"Balint","year":"2020","journal-title":"Biochimie"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s10020-023-00656-z","article-title":"Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder","volume":"29","author":"Zhang","year":"2023","journal-title":"Mol Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1006\/bbrc.1996.0014","article-title":"Glycated albumin promotes a generalized vasculopathy in the db\/db mouse","volume":"218","author":"Cohen","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1161\/STROKEAHA.123.045601","article-title":"Association of sdLDL-C with incident carotid plaques with stable and vulnerable morphology: a prospective cohort study","volume":"55","author":"Ma","year":"2024","journal-title":"Stroke"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.pcad.2020.04.009","article-title":"Small dense low-density lipoprotein-cholesterol (sdLDL-C): analysis, effects on cardiovascular endpoints and dietary strategies","volume":"63","author":"Santos","year":"2020","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1846081\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:19:07Z","timestamp":1780287547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1846081\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":49,"alternative-id":["10.3389\/fnut.2026.1846081"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1846081","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"article-number":"1846081"}}